Embolic compositions and methods

Patent metadata

Field	Value
Publication number	US-12397087-B2
Application number	US-202318216426-A
Country	US
Kind code	B2
Filing date	Jun 29, 2023
Priority date	May 15, 2018
Publication date	Aug 26, 2025
Grant date	Aug 26, 2025

Abstract

An embolization system and methods for controlling solidification of embolic compositions comprising a first and a second embolic component that react with each other in vivo at a target site to form an embolic material, with the embolic components being dilutable in physiological fluids so that they do not form an embolic composition at a site that is not desired.

First claim

What is claimed is:

1. An embolization system for controlling solidification in vivo of an embolic composition, comprising
a first fluid supply containing a first liquid,
a second fluid supply containing a second liquid,
a water soluble polymer that comprises at least two functional groups that comprise an unsaturated hydrocarbon group, wherein the water soluble polymer comprises a hydrophilic polymer with 2 to 4 arms extending from a core, each arm having a functional group capable of undergoing free radical polymerization, and the hydrophilic polymer having a molecular weight not less than 3000 Daltons between the functional groups,
an initiator, and
a co-initiator,
with the initiator being disposed in one of the first liquid and the second liquid and the co-initiator being disposed in the other of the first liquid and the second liquid,
with the water soluble polymer being disposed in at least one of the first liquid and the second liquid,
wherein a mixture of the first liquid and the second liquid provides for reaction of the initiator and the co-initiator to form a radical initiator for a free radical polymerization of the functional groups to covalently crosslink the water soluble polymer to form an embolization material.

2. The embolization system of claim 1 wherein a dilution of a mixture of the first liquid and the second liquid prevents formation of the embolization material in less than 120 seconds as measured by an in vitro gel time test, wherein the dilution is in a range of from 100% to 400% v/v.

3. The embolization system of claim 1 further comprising at least one further precursor that is crosslinked to form the embolic material, wherein the embolic material is a hydrogel.

4. The embolization system of claim 1 wherein a 1:1 mixture of the first liquid and the second liquid forms the embolization material in no more than 5 seconds as measured by an in vitro gel time test.

5. The embolization system of claim 1 wherein the at least two functional groups comprise an acrylate group and/or a methacrylate group.

6. The embolization system of claim 1 wherein a molecular weight, Mn, between the at least two functional groups is at least 4000 Daltons.

7. The embolization system of claim 1 wherein the co-initiator comprises iron and is present at a concentration in a range from 0.2 to 200 mM.

8. The embolization system of claim 1 wherein the initiator is tert-butyl-hydroperoxide in a concentration range from 50 to 10,000 parts per million (ppm).

9. The embolization system of claim 1 wherein the embolization material comprises a hydrogel that has a compression modulus from 1500-100,000 Pa and a swellability of 20%-300% w/w.

10. The embolization system of 1 wherein the co-initiator comprises Fe2+, Cr2+, V2+, Ti3+, Co2+, or Cu+ and wherein the initiator comprises a peroxide group, an alkyl hydrogen peroxide group, or a persulfate.

11. The embolization system of claim 1 wherein the water soluble polymer comprises a polysaccharide, hyaluronic acid, a protein, a peptide, a polyalkylene oxide, a polyethylene glycol (PEG), or a polyvinyl alcohol.

12. The embolization system of claim 1 wherein the water soluble polymer comprises at least 80% w/w PEG.

13. The embolization system of claim 1 wherein a molecular weight of the water soluble polymer ranges from 3000 to 200,000 Daltons.

14. The embolization system of claim 1 wherein a concentration of the water soluble polymer in the first liquid is from 5-50% w/w.

15. The embolization system of claim 1 wherein the first liquid and/or second liquid comprises a radiopaque contrast medium.

16. The embolization system of claim 1 wherein the first liquid and the second liquid are aqueous liquids independently selected to have a viscosity suitable for passage through catheter lumens.

17. The embolization system of claim 1 wherein the embolization material is formed when the mixture is diluted 100%-250% v/v, wherein the embolization material is formed within 5 seconds when the mixture is diluted by less than 100% v/v, and wherein formation is measured by an in vitro gel time.

18. An embolization system comprising:
a coaxial catheter comprising an inner catheter and an outer catheter,
an adaptor,
a first fluid supply containing a first liquid,
a second fluid supply containing a second liquid,
an initiator, and
a co-initiator,
with the initiator being disposed in one of the first liquid and the second liquid and the co-initiator being disposed in the other of the first liquid and the second liquid,
a water soluble polymer disposed in at least one of the first liquid and the second liquid, wherein the water soluble polymer comprises at least two functional groups that comprise an unsaturated hydrocarbon group, wherein the water soluble polymer comprises a hydrophilic polymer with 2 to 4 arms extending from a core, each arm having a functional group capable of undergoing free radical polymerization, and the hydrophilic polymer having a molecular weight not less than 3000 Daltons between the functional groups,
wherein a mixture of the first liquid and the second liquid provides for reaction of the initiator and the co-initiator to form a radical initiator for a free radical polymerization of the functional groups to covalently crosslink the water soluble polymer to form an embolization material, and
wherein the inner catheter has an outer diameter ranging from 0.005 to 0.1 inches, the outer catheter has an inner diameter ranging from 0.01 to 0.2 inches, and the outer diameter of the inner catheter being selected to pass through the outer catheter, and
wherein the adaptor is connectable to the inner catheter and the outer catheter.

19. The embolization system of claim 18 wherein a distal tip of the inner catheter is displaceable distally to a distal tip of the second catheter—by a distance adjustable from more than 0 mm to no more than 200 mm.

20. The embolization system of claim 18 wherein the embolization material effectively embolizes a vascular lumen associated with an aneurysm.

21. The embolization system of claim 18 wherein the embolization material effectively embolizes a vascular lumen associated with a tumor.

22. An embolization system for controlling solidification in vivo of an embolic composition, comprising
a first fluid supply containing a first liquid,
a second fluid supply containing a second liquid,
a water soluble polymer that comprises at least two functional groups that comprise an unsaturated hydrocarbon group, wherein the water soluble polymer comprises a hydrophilic polymer with 2 to 4 arms, each arm having a functional group, and the hydrophilic polymer having a molecular weight not less than 3000 Daltons between the functional groups,
an initiator, and
a co-initiator,
with the initiator being disposed in one of the first liquid and the second liquid and the co-initiator being disposed in the other of the first liquid and the second liquid,
with the water soluble polymer being disposed in at least one of the first liquid and the second liquid,
wherein a mixture of the first liquid and the second liquid provides for reaction of the initiator and the co-initiator to form a radical initiator for a free radical polymerization of the functional groups to covalently crosslink the water soluble polymer to form an embolization material,
wherein the water soluble polymer comprises polyethylene glycol diacrylate or a derivative thereof.

23. The embolization system of

Assignees

• Incept Llc

Inventors

• Sawhney Amarpreet S
• Claesson Hans
• Lareau Raymond
• Billings Douglas

Classifications

• C08F120/28

  containing no aromatic rings in the alcohol moiety · CPC title

• A61L2300/44

  Radioisotopes, radionuclides · CPC title

• A61L24/06

  obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)} · CPC title

• A61L24/02

  containing inorganic materials · CPC title

• A61L24/0031

  Hydrogels or hydrocolloids · CPC title